Publication | Closed Access

Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance

Breast OncologyAnnexin A3MedicineApoptosisCell DeathImmune Checkpoint InhibitorBreast CancerPoor PrognosisTumor SuppressorRadiation OncologyOncologyCell BiologyTumor Microenvironment